Results per Page:
‘If you want to go far, go together’
Fred Hutch scientist Dr. Jennifer Adair partners with colleagues around the globe to make gene therapies more effective and more widely available
Early research may show new way to block dengue and Zika virus
Scientists find different flavor of broadly neutralizing antibody that could lead to new vaccines for growing threat
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
New study highlights lack of diversity and inclusion in vaccine clinical trials
Analysis shows certain racial/ethnic groups and older people aren’t being adequately represented and trial reporting guidelines aren’t being followed
In Uganda: Treating twin threats of HIV and cancer
Dr. Sue Desmond-Hellmann of the Bill & Melinda Gates Foundation visits Hutch researchers in Kampala
UCI-Fred Hutch collaboration turns 10
In Uganda, innovation and persistence allow a 'sustainable cancer program' to take root
The pride of Fred Hutch
HIV Vaccine Trials Network veteran Steven Wakefield named a grand marshal in Seattle Pride Parade
Top 10 tips to cut your cancer risk
Vegetables and exercise may not be glamorous, but they could save your life, expert report confirms
First human antibody found to block Epstein-Barr virus
Early research could open new path for vaccine against EBV-related cancers, mononucleosis
New antibody and unique binding site offer possible paths to malaria prevention
Led by NIH, Fred Hutch researchers, early study holds promise for direct infusion or vaccine design
Meet Global Oncology's deputy program head
Key early experiences shaped Dr. Thomas Uldrick's path toward HIV-associated cancers, global health
Meet Peru's HIV superhero
By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic
Grappling with breast cancer and health disparities around the globe
Fred Hutch global cancer initiative uses collaborations, common sense strategies to tackle health disparities in low- and middle-income countries
Closing the breast cancer divide in sub-Saharan Africa
Clinical trial in Uganda will test alternative diagnostic tool and oral chemotherapy, study genetic differences
Dr. Hootie Warren takes helm of Fred Hutch Global Oncology
Immunotherapy researcher, cancer doctor set to lead a new worldwide revolution in care
Burkitt's Lymphoma Fund for Africa partners with Fred Hutch to carry on its founder's passion
Partnering with Fred Hutch Global Oncology, Burkitt’s Lymphoma Fund for Africa carries on its founder’s passion
In Uganda, strengthening a partnership against cancer
A ‘compelling and inspiring visit’ yields renewed commitment by Fred Hutch, Ugandan leaders
A little card with a big task: Saving lives from CML
Researchers develop low-cost, paper-based diagnostic for use in low-income countries
Gene therapy goes global: Portable device could make future cancer, HIV cures affordable
Portable 'gene therapy in a box' could make future cancer, HIV cures affordable in developing countries